What daily clinical and laboratory assessments and management interventions are recommended for a patient with dengue fever to monitor for complications?

Daily Management and Monitoring of Dengue Fever

All dengue patients require daily clinical assessment for warning signs and serial laboratory monitoring with complete blood count (hematocrit and platelet count) to detect the critical phase, which typically occurs between days 3-7 of illness.

Daily Clinical Assessment

Monitor for warning signs that indicate progression to severe dengue and impending shock 1:

• Abdominal pain or tenderness - key indicator of plasma leakage
• Persistent vomiting - prevents adequate oral hydration
• Clinical fluid accumulation (ascites, pleural effusion)
• Mucosal bleeding (gum bleeding, epistaxis, hematemesis, melena)
• Lethargy or restlessness - early signs of shock
• Liver enlargement >2 cm
• Rapid drop in platelet count with rising hematocrit

Physical Examination Focus

Perform daily:

• Vital signs including orthostatic blood pressure and pulse pressure (narrowing <20 mmHg indicates shock)
• Capillary refill time and peripheral perfusion
• Tourniquet test if not previously positive
• Skin examination for petechiae, purpura, or erythema (hand impression test) 2
• Abdominal examination for hepatomegaly and ascites
• Respiratory examination for pleural effusion

Daily Laboratory Monitoring

Essential Daily Tests

Complete blood count with hematocrit and platelet count - this is the cornerstone of monitoring 3, 1:

• Hematocrit: Rising hematocrit (≥20% increase from baseline) indicates plasma leakage and heralds the critical phase. Check every 12-24 hours during days 3-7
• Platelet count: Typically drops during critical phase, but thrombocytopenia alone does not predict bleeding - 14% of patients with platelets <20,000/µL had no bleeding 3
• White blood cell count: Progressive leukopenia is common

Additional Monitoring Based on Severity

For patients with warning signs or severe dengue:

• Serum lactate - elevated levels indicate tissue hypoperfusion 4
• Liver enzymes (AST/ALT) - monitor for hepatitis
• Coagulation profile if bleeding present
• Serum albumin - hypoalbuminemia reflects plasma leakage
• Blood glucose - hypoglycemia can occur in severe cases

Point-of-Care Ultrasound (POCUS)

Serial ultrasound assessment can detect plasma leakage before clinical manifestations 4:

Key findings to assess daily during critical phase:

• Gallbladder wall thickening (>3 mm) - earliest sign
• Pleural effusion (right side more common)
• Ascites - free fluid in Morrison's pouch, perisplenic space
• Pericardial effusion in severe cases

These sonographic findings often precede clinical shock and facilitate early intervention 4.

Disease Phase Recognition

Febrile Phase (Days 1-3)

• High fever (often biphasic pattern)
• Monitor for warning signs
• Daily CBC not mandatory if patient stable

Critical Phase (Days 3-7)

• This is when complications occur - requires most intensive monitoring
• Fever typically defervesces (74.5% by day 10) 3
• Important pitfall: 28% of patients remain afebrile for >72 hours despite declining platelets - fever resolution does NOT mean disease resolution 3
• Plasma leakage peaks during this phase
• Daily or twice-daily hematocrit and platelet monitoring essential

Recovery Phase (After Day 7)

• Reabsorption of extravasated fluid
• Hematocrit stabilizes or decreases
• Platelet count begins rising
• Can reduce monitoring frequency

Complications to Monitor

Severe Dengue Manifestations

1. Severe plasma leakage leading to:

   • Dengue shock syndrome (mortality 1-5%) 1
   • Respiratory distress from pleural effusion/ascites

2. Severe bleeding:

   • Most common: epistaxis (36.3%), gum bleeding (27.2%) 3
   • Serious: hematemesis, melena, menorrhagia

3. Organ impairment:

   • Hepatitis with transaminitis
   • Acute kidney injury
   • Encephalopathy
   • Myocarditis

4. Rare but life-threatening (Expanded Dengue Syndrome):

   • Hemophagocytic lymphohistiocytosis (HLH) - suspect if persistent fever, worsening cytopenias, and liver dysfunction beyond expected course; check ferritin, triglycerides, fibrinogen 5
   • Intravascular hemolysis 5

Management Interventions

Hydration Strategy (Phase-Dependent)

Febrile phase: Oral fluids 2-3 L/day if tolerating

Critical phase with warning signs:

• IV crystalloids (normal saline or Ringer's lactate)
• Initial bolus 5-7 mL/kg over 1-2 hours
• Reassess hematocrit after 2 hours
• Adjust rate based on clinical response and hematocrit trend

Severe dengue/shock:

• Aggressive fluid resuscitation 10-20 mL/kg bolus over 15-30 minutes
• May require colloids if inadequate response
• Monitor for fluid overload during recovery phase

Transfusion Thresholds

• Platelets: Transfuse only for active bleeding or before invasive procedures, NOT based on count alone 3
• Packed red blood cells: For significant bleeding with hemodynamic compromise
• Fresh frozen plasma/cryoprecipitate: For coagulopathy with bleeding

Supportive Care

• Avoid NSAIDs and aspirin - use paracetamol for fever/pain
• Avoid intramuscular injections - risk of hematoma
• Cautious fluid management - overhydration during recovery causes pulmonary edema

Hospitalization Criteria

Admit patients with:

• Any warning signs
• Comorbidities (pregnancy, diabetes, hypertension, elderly, infants)
• Social factors preventing adequate follow-up
• Inability to maintain oral hydration

Key insight: Hospital admission should NOT be based solely on platelet count - structured outpatient monitoring is appropriate for uncomplicated dengue without warning signs 3.

Diagnostic Testing

Within 7 days of symptom onset: RT-PCR or NS1 antigen testing on serum 6

After 7 days: IgM antibody testing 6

Pregnant women: Test for both dengue and Zika virus by NAAT due to risk of maternal death, hemorrhage, preeclampsia, and vertical transmission 6